News Center

位置：

Honors Announcement

Group News

Media Reports

“City of Happiness, Labor Is the Most Beautiful” Team Diary | Shijiazhuang No. 4 Pharmaceutical Liquid Formulation R&D Team: Crafting Quality Medicines with Artisan Spirit, Safeguarding Health Through Innovation

Category:

Media Reports

发布时间：2025-09-10

【概要描述】 On the battlefield of pharmaceutical R&D, there is a dedicated group of individuals who make the laboratory their stronghold and harness their ingenuity to break through technological barriers. Today, we step into Shijiazhuang Sihua Pharmaceutical to meet the Liquid Formulation R&D Team—a team that safeguards human health with both wisdom and hard work—and to explore their unwavering commitment to excellence on the path of pharmaceutical innovation.

“City of Happiness, Labor Is the Most Beautiful” Team Diary | Shijiazhuang No. 4 Pharmaceutical Liquid Formulation R&D Team: Crafting Quality Medicines with Artisan Spirit, Safeguarding Health Through Innovation

Narrator: Stay tuned for the “Diary of the Most Beautiful Labor Teams in the City of Happiness” series, jointly produced by the Shijiazhuang Municipal Federation of Trade Unions and Shijiazhuang Radio and Television Station.

On the battlefield of pharmaceutical R&D, there is a dedicated group of individuals who make the laboratory their stronghold and harness their ingenuity to break through technological barriers. Today, we step into Shijiazhuang Sihua Pharmaceutical to meet the Liquid Formulation R&D Team—a team that safeguards human health with both wisdom and hard work—and to explore their journey of artisanal dedication on the path of pharmaceutical innovation.

Stepping into the R&D laboratory of Shijiazhuang Sihua Pharmaceutical, researchers from the liquid formulation development team are intently engaged in data analysis and experimental optimization. Led by Wang Hui, this team has for many years been deeply committed to the research, development, and application of large-volume injectables, consistently pushing past technological barriers in pharmaceutical innovation through a scientifically rigorous approach and an unwavering pursuit of excellence.

2024 This year, the team achieved a major technological breakthrough. Building on their existing R&D strengths, they devoted all their efforts to developing neutral peritoneal dialysis solution. Dual-chamber bag product. This product not only significantly reduces pain during medication administration but also effectively lowers the risk of peritoneal sclerosis and peritonitis.

Upon approval, the product will fill a critical gap in Hebei Province’s market for two-chamber bag neutral peritoneal dialysis solution, bringing hope for life to thousands of patients.

Head of the Liquid Formulation R&D Team at Shijiazhuang Sihua Pharmaceutical Wang Hui: Pharmaceutical R&D is a matter of life and death for patients; not a single piece of data or experiment can be taken lightly. During the development of our dual-chamber bag product, our team spent several consecutive months stationed in the laboratory, rigorously validating every step—from raw-material selection to process optimization—so that our product can truly alleviate patients’ suffering. No matter how arduous or exhausting it may be, it is all worth it.

Narrator: Innovation is the core competitive advantage of this team. Since 2021 Since the beginning of the year, team members have cumulatively earned 92 a drug approval document. Among them, pentoxifylline injection, Peritoneal dialysis solution, lactate (G-2.5% ) and several other products have become the first in the nation to pass the evaluation. Behind these achievements lies the team’s unwavering commitment to technological innovation.

Head of the Liquid Formulation R&D Team at Shijiazhuang Sihua Pharmaceutical Wang Qiaru: In studies aimed at optimizing the stability of injectable formulations, We experimented with dozens of formulation combinations and endured countless failures, yet no one ever lost heart. Instead, we encouraged one another and worked together to overcome every challenge. It is precisely this unwavering spirit of perseverance that has enabled us to achieve breakthroughs in technology time and again.

Narrator: While pursuing technological breakthroughs, the team places equal emphasis on passing down the spirit of craftsmanship. Through mentorship programs that pair experienced staff with newcomers and hands-on project training, young researchers are rapidly developing their skills. Today, it is common to see mentors and mentees collaborating and tackling challenges side by side in the lab, creating a virtuous cycle in which seasoned experts guide the next generation while fresh perspectives drive innovation.

Members of the Liquid Formulation R&D Team at Shijiazhuang Sihua Pharmaceutical Zhang Di: When I first joined the team, I started with the fundamentals under the guidance of my senior colleagues, who shared their expertise generously and provided hands-on mentorship in tackling technical challenges. Today, I am able to independently lead projects. This legacy of knowledge transfer has not only strengthened the team’s overall capabilities but has also deepened my understanding of the responsibilities that come with being a pharmaceutical professional.

Narrator: From filling technological gaps to safeguarding the health and well-being of countless families, the liquid formulation R&D team at Shijiazhuang Sihua Pharmaceutical has embodied its mission through meticulous craftsmanship and driven the future with innovation. Thanks to its outstanding R&D achievements, the team has, by 2021 Awarded the title of “Advanced Department” by the Group this year.

Head of the Liquid Formulation R&D Team at Shijiazhuang Sihua Pharmaceutical Wang Hui: Looking ahead, we will remain committed to advancing cutting-edge pharmaceutical technologies, developing more efficient and safe medicines, and intensifying our efforts in talent cultivation to build a robust R&D team capable of tackling the most challenging projects. We are determined to make a greater contribution—through concrete actions—to the development of Shijiazhuang’s biopharmaceutical industry and to safeguarding the health of the people.

Keywords:

None

Shijiazhuang Daily | Reading the Data, Seeing the Development | In the First Half of the Year, Shijiazhuang’s Value Added by Industries Above Designated Size Recorded Double-Digit Year-on-Year Growth—What Transformative Breakthroughs Do These Striking Figures Reflect?

None